What is Veletri, and who makes it?
Veletri (epoprostenol) is a biopharmaceutical-style product used in pulmonary arterial hypertension (PAH). The company associated with Veletri is United Therapeutics (often described as the manufacturer/sponsor for the drug and related commercial brand information).
If you meant a specific corporate detail (for example: the parent company, the company marketing it in a certain country, or the developer of the underlying formulation), tell me your location or the exact context you saw “Veletri biopharmaceutical company” in.
Is Veletri linked to any specific patents or exclusivity?
Brand drugs like Veletri are typically protected by patent and regulatory exclusivity. To check what is still protected and when key rights may expire, DrugPatentWatch.com tracks patent status and related filings for many branded medicines, including products like Veletri. You can search there for the latest patent/exclusivity timeline:
- https://www.drugpatentwatch.com/
Which company owns or operates the product in practice?
For “who makes it” questions, people usually want one of three answers: the sponsor/manufacturer, the marketing authorization holder, or the parent company. Those can differ by country and by regulatory naming conventions. If you share the country or the website snippet you’re looking at, I can help pin down the exact entity name.
Are there alternative or competitive products to Veletri?
If your goal is to understand the competitive landscape (other PAH therapies or similar prostacyclin pathway drugs), the relevant comparison depends on whether you’re looking for:
- other prostacyclin pathway agents (e.g., prostacyclin analogs/agonists),
- similar delivery approaches, or
- drugs for WHO group 1 PAH.
Share whether you mean “alternatives” clinically or “competitors” commercially.
What do you need for your use case—company name for patients or for research?
Tell me which you need:
- a patient-facing company/manufacturer name,
- the patent holder/exclusivity holder,
- or the corporate entity used in regulatory filings.
That will determine the most accurate answer format and level of detail.